Skip to main content
Steven Artandi, MD, Oncology, Stanford, CA

Steven E Artandi MD


Director, Stanford Cancer Institute

Join to View Full Profile
  • 265 Campus DrLokey 2165Stanford, CA 94305

Dr. Artandi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1997 - 2000
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1995 - 1997
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2022

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2009

Publications & Presentations

PubMed

Press Mentions

  • Reimagining Cancer: Stanford Medicine Magazine Reports on Advances in Cancer Science, Prevention, Care
    Reimagining Cancer: Stanford Medicine Magazine Reports on Advances in Cancer Science, Prevention, CareJanuary 27th, 2025
  • Addressing Care Gaps for Cancer Survivors
    Addressing Care Gaps for Cancer SurvivorsDecember 4th, 2024
  • Oncologists Eye GLP-1s' Potential Role in Cancer Care
    Oncologists Eye GLP-1s' Potential Role in Cancer CareJuly 19th, 2024
  • Join now to see all

Grant Support

  • Stanford Cancer InstituteSTANFORD UNIVERSITY2007–2027
  • Stanford Cancer InstituteSTANFORD UNIVERSITY2007–2027
  • Stanford Cancer InstituteSTANFORD UNIVERSITY2007–2027
  • Stanford Cancer InstituteSTANFORD UNIVERSITY2007–2027
  • Stanford Cancer InstituteSTANFORD UNIVERSITY2007–2025
  • Stanford Cancer InstituteSTANFORD UNIVERSITY2007–2025
  • Defining The Telomerase Holoenzyme In Progenitor Cells With AgingNational Institute On Aging2010–2012
  • Telomeres, Telomerase And Tumor ProgressionNational Cancer Institute2008–2012
  • Understanding Telomerase And WNT Signaling In Stem Cell AgingNational Institute On Aging2011
  • Mouse Aging CoreNational Institute On Aging2011
  • Studying A Human Stem Cell Disease Using IPS TechnologyNational Heart, Lung, And Blood Institute2010
  • Regulation Of The Telomerase Protein Component In CancerNational Cancer Institute2006–2010
  • Telomeres, Telomerase And Tumor ProgressionNational Cancer Institute2007
  • Telomeres, Telomerase And Tumor ProgerssionNational Cancer Institute2006
  • Telomeres, Telomerase And Tumor ProgerssionNational Cancer Institute2005
  • Novel Functions For Telomerase Enzyme Complex In VivoNational Cancer Institute2005
  • Telomere Dysfunction, Genomic Instability And CancerNational Cancer Institute2000–2005

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: